Search

everythinglearnresearchcommunity

for

Search:↓

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

PGD2 stops hair growth and is higher in bald men with AGA.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

SFRP2 and PTGDS may be key factors in female hair loss.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Melatonin improves cashmere goat hair quality by increasing follicles and reducing skin aging.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Higher levels of the DP2 receptor may lead to hair loss.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.